Sonnet BioTherapeutics Holdings, Inc. (SONN) .
本页证实的标准:
SharesGrow 综合评分： 43/100 其中 2/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-269,068.00 | $41.7M | $-9.08M | -21.8% |
| 2017 | $-175,138.00 | $41.43M | $-6.79M | -16.4% |
| 2018 | $-126,904.00 | $30.73M | $-6.85M | -22.3% |
| 2019 | $-163,753.00 | $40.61M | $-5.03M | -12.4% |
| 2020 | $-17,159.00 | $0.00 | $-31.06M | - |
| 2021 | $-2,507.83 | $483.63K | $-25.01M | -5170.5% |
| 2022 | $-1,203.05 | $349.94K | $-29.77M | -8508.3% |
| 2023 | $-145.12 | $147.81K | $-18.83M | -12741.6% |
| 2024 | $-11.35 | $18.63K | $-7.44M | -39929.3% |
| 2025 | $-3.95 | $1M | $-16.11M | -1611.3% |
